Clinical trial
Randomized, Controlled Trial of SCH 56592 Oral Suspension Versus Fluconazole Suspension in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients
NCT00002446 is registered in ClinicalTrials.gov with Schering-Plough as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Controlled Trial of SCH 56592 Oral Suspension Versus Fluconazole Suspension in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients
- Lead sponsor
- Schering-Plough
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 31, 1998
- Completion date
- Not reported
- Enrollment
- 300
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.